{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:07:11Z","timestamp":1785424031939,"version":"3.56.0"},"reference-count":36,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002635","name":"INHA UNIVERSITY","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002635","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/01easw929","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Glutaric aciduria type 1 (GA1) is a rare neurometabolic disorder caused by glutaryl-CoA dehydrogenase (GCDH) deficiency, leading to the accumulation of neurotoxic metabolites that can cause both acute encephalopathic crises and progressive, insidious brain injury. Current management primarily relies on a protein-restricted diet, which remains therapeutically insufficient and burdensome for patients, highlighting the need for disease-modifying therapies. In this study, we established a novel GA1 mouse model using CRISPR\/Cas9 technology and evaluated the preclinical efficacy of systemic recombinant adeno-associated virus (rAAV)-mediated gene therapy. Under standard dietary conditions without high-lysine challenge, our GA1 model exhibited sustained cerebral and hepatic glutaric acid (GA) accumulation and distinct chronic vacuolation in the hippocampus and cerebellum, mirroring the insidious-onset GA1 phenotype. Five-week-old mice received a single intravenous injection of rAAV-hGCDH using either rAAV2\/8 or rAAV2\/9 serotypes. Systemic rAAV-mediated gene therapy significantly reduced GA accumulation and attenuated chronic neuropathological changes in this GA1 mouse model for both serotypes. Our findings support the hypothesis that peripheral metabolic correction may play an important role in preventing the chronic neuropathological changes associated with GCDH deficiency. However, further investigation using tissue-specific expression systems is required to definitively delineate the relative contributions of hepatic versus central GCDH restoration to the observed neuroprotection.<\/jats:p>","DOI":"10.3390\/ijms27125569","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:09:17Z","timestamp":1782270557000},"page":"5569","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic AAV-hGCDH Gene Therapy Alleviates Glutaric Acid Accumulation and Attenuates Chronic Brain Vacuolation in a Novel Mouse Model of Glutaric Aciduria Type I"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0893-0512","authenticated-orcid":false,"given":"Su Jin","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Inha University Hospital, Inha University College of Medicine, Incheon 22332, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Hwa","family":"Nam","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, College of Medicine, Ewha Womans University, Seoul 07804, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5972-6191","authenticated-orcid":false,"given":"Eun Young","family":"Joo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Inha University Hospital, Inha University College of Medicine, Incheon 22332, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisun","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Inha University Hospital, Inha University College of Medicine, Incheon 22332, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3374-3911","authenticated-orcid":false,"given":"Saeyoung","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, College of Medicine, Ewha Womans University, Seoul 07804, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3174-8965","authenticated-orcid":false,"given":"Sung-Chul","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, College of Medicine, Ewha Womans University, Seoul 07804, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Kyu","family":"Jin","sequence":"additional","affiliation":[{"name":"School of Medicine, Sungkyunkwan University, Suwon 16419, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"ref_1","unstructured":"Adam, M.P., Bick, S., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (2019). Glutaric Acidemia Type 1, GeneReviews\u00ae [Internet], Available online: https:\/\/nih.gov."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0006-2944(75)90149-0","article-title":"Glutaric aciduria: Inherited deficiency of glutaryl-CoA dehydrogenase activity","volume":"13","author":"Goodman","year":"1975","journal-title":"Biochem. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jimd.12033","article-title":"Patterns, evolution, and severity of striatal injury in insidious- vs acute-onset glutaric aciduria type 1","volume":"42","author":"Boy","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1203\/01.pdr.0000219387.79887.86","article-title":"Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency","volume":"59","author":"Kolker","year":"2006","journal-title":"Pediatr. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ana.25233","article-title":"Newborn screening: A disease-changing intervention for glutaric aciduria type 1","volume":"83","author":"Boy","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ymgme.2012.05.024","article-title":"Glutaric acidemia type 1: Outcomes before and after expanded newborn screening","volume":"106","author":"Viau","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2020.09.007","article-title":"Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades","volume":"131","author":"Strauss","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bernstein, L., Coughlin, C.R., Drumm, M., Yannicelli, S., and Rohr, F. (2020). Inconsistencies in the Nutrition Management of Glutaric Aciduria Type 1: An International Survey. Nutrients, 12.","DOI":"10.3390\/nu12103162"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.6065\/apem.2550134.067","article-title":"Unraveling PEX6: Insights into very-long-chain fatty acid levels and peroxisome biogenesis disorders in pediatric populations","volume":"31","author":"Ahangari","year":"2026","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101276","DOI":"10.1016\/j.omtm.2024.101276","article-title":"Systemic delivery of AAV-GCDH ameliorates HLD-induced phenotype in a glutaric aciduria type I mouse model","volume":"32","author":"Barallobre","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.fmre.2022.08.013","article-title":"Treatment of glutaric aciduria type I (GA-I) via intracerebroventricular delivery of GCDH","volume":"2","author":"Guo","year":"2022","journal-title":"Fundam. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/JVI.79.1.214-224.2005","article-title":"Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice","volume":"79","author":"Nakai","year":"2005","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/hmg\/11.4.347","article-title":"Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I","volume":"11","author":"Koeller","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/brain\/awl009","article-title":"A diet-induced mouse model for glutaric aciduria type I","volume":"129","author":"Zinnanti","year":"2006","journal-title":"Brain"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41436-020-00971-4","article-title":"Impact of newborn screening and quality of therapy on the neurological outcome in glutaric aciduria type 1: A meta-analysis","volume":"23","author":"Boy","year":"2021","journal-title":"Genet. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"eadf4086","DOI":"10.1126\/scitranslmed.adf4086","article-title":"Rescue of glutaric aciduria type I in mice by liver-directed therapies","volume":"15","author":"Barzi","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1471-4159.2006.03813.x","article-title":"Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency","volume":"97","author":"Sauer","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1038\/s41467-023-39554-7","article-title":"AAV11 enables efficient retrograde targeting of projection neurons and enhances astrocyte-directed transduction","volume":"14","author":"Han","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jconrel.2025.01.021","article-title":"An engineered adeno-associated virus mediates efficient blood-brain barrier penetration with enhanced neurotropism and reduced hepatotropism","volume":"379","author":"Luo","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Parajuli, S., Gallagher, T., and Flotte, T.R. (2026). Immune Toxicities in AAV Gene Therapy: Overview for Clinicians. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27073196"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: Overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1706910","article-title":"Gene Therapy","volume":"381","author":"High","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41551-026-01643-5","article-title":"Engineering challenges and translational opportunities in emerging gene delivery platforms","volume":"10","author":"Ma","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"105834","DOI":"10.1016\/j.ebiom.2025.105834","article-title":"Viral and non-viral vectors in gene therapy: Current state and clinical perspectives","volume":"118","author":"Geng","year":"2025","journal-title":"eBioMedicine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/rcm.3053","article-title":"Analysis of organic acid markers relevant to inherited metabolic diseases by ultra-performance liquid chromatography\/tandem mass spectrometry as benzofurazan derivatives","volume":"21","author":"Santa","year":"2007","journal-title":"Rapid Commun. Mass. Spectrom."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s43657-024-00205-6","article-title":"Metabolomics Reveals Reasons for the Efficacy of Acupuncture in Migraine Patients: The Role of Anaerobic Glycolysis and Mitochondrial Citrate in Migraine Relief","volume":"5","author":"Gao","year":"2025","journal-title":"Phenomics"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Guan, J.-S., Chen, K., Si, Y., Kim, T., Zhou, Z., Kim, S., Zhou, L., and Liu, X. (2022). Process Improvement of Adeno-Associated Virus Production. Front. Chem. Eng., 4.","DOI":"10.3389\/fceng.2022.830421"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1046-2023(02)00219-0","article-title":"Production methods for gene transfer vectors based on adeno-associated virus serotypes","volume":"28","author":"Grimm","year":"2002","journal-title":"Methods"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.joim.2024.01.001","article-title":"Melittin analog p5RHH enhances recombinant adeno-associated virus transduction efficiency","volume":"22","author":"Meng","year":"2024","journal-title":"J. Integr. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/hgtb.2015.051","article-title":"Comparative Analysis of Cesium Chloride- and Iodixanol-Based Purification of Recombinant Adeno-Associated Viral Vectors for Preclinical Applications","volume":"26","author":"Strobel","year":"2015","journal-title":"Hum. Gene Ther. Methods"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2174\/1389201016666150505122228","article-title":"Scalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties","volume":"16","author":"Qu","year":"2015","journal-title":"Curr. Pharm. Biotechnol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5569\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:17:55Z","timestamp":1782533875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27125569"],"URL":"https:\/\/doi.org\/10.3390\/ijms27125569","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]}}}